Please verify your age.
Europe’s cannabis market is changing, but its health impact remains uncertain. Stronger resin, new products and diverging national laws complicate the picture. Here’s what the latest EUDA evidence reveals—and what the figures cannot tell us about use and harm.
From Germany's Cannabis Act to Spain's hospital pharmacies, Europe is rewriting the rules on cannabis medicine. We unpack the 17.6% CAGR behind a fourfold rise in market value, the segments pulling ahead, from indica flower to CBD oils, and the barriers still slowing patient access.
Germany's prices are tumbling, the UK's patient count is climbing and Portugal is shipping tonnes across the continent. We break down the figures behind Europe's fastest-moving cannabis markets, from Swiss pilot trials to the 2029 forecasts, and what it all means for growers.
New York officials are warning about cannabis drinks sold by unauthorized retailers, citing consumer safety risks and pressure on licensed dispensaries. No new blanket ban has been announced, while proposals to open sales to liquor stores remain unsettled.
Europe